HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by WILCOX, G. R. Articles by TRUDINGER, B. J. Search for Related Content PubMed PubMed Citation Articles by WILCOX, G. R. Articles by TRUDINGER, B. J.

Fetal Platelet Consumption: A Feature of Placental Insufficiency

From the Fetal Welfare Laboratory, Department of Obstetrics and Gynecology, University of Sydney at Westmead Hospital, Westmead, New South Wales, Australia

Abstract

The involvement of fetal platelets in placental insufficiency was investigated. Platelet life span and the rate of platelet turnover were measured by a novel technique in fetuses with moderate and severe placental insufficiency and in controls. This procedure involves the measurement of platelet count and concentration of free glycocalicin in plasma. Placental insufficiency was defined by antenatal Doppler ultrasound analysis of the umbilical artery waveform, which was used to categorize the subjects according to whether their systolic-diastolic ratios were normal, moderately raised, or severely raised. Mean platelet life span in fetuses affected by placental insufficiency was only 60% of the normal fetal platelet life span (P<.001). In addition, affected fetuses had a higher rate of platelet turnover, reflected in an elevated plasma glycocalicin concentration (4.06 ± 0.19 versus 3.28 ± 0.15 jug/mL for severe placental insufficiency and control fetuses, respectively; P<.01). Platelet life span did not differ between the moderate and severe placental insufficiency groups. We hypothesize that the observed changes in platelet life span and turnover result from increased platelet activation, which plays a role in the development of placental insufficiency.

This article has been cited by other articles:

				B. Trudinger, J. Z. Song, Z. H. Wu, and J. Wang Placental Insufficiency Is Characterized by Platelet Activation in the Fetus Obstet. Gynecol., May 1, 2003; 101(5): 975 - 981. [Abstract] [Full Text] [PDF]

				A. A. BASCHAT, U. GEMBRUCH, I. REISS, L. GORTNER, C. P. WEINER, and C. R. HARMAN Absent Umbilical Artery End-Diastolic Velocity in Growth-Restricted Fetuses: A Risk Factor for Neonatal Thrombocytopenia Obstet. Gynecol., August 1, 2000; 96(2): 162 - 166. [Abstract] [Full Text] [PDF]

				L. Myatt, R. B. Rosenfield, A. L.W. Eis, D. E. Brockman, I. Greer, and F. Lyall Nitrotyrosine Residues in Placenta: Evidence of Peroxynitrite Formation and Action Hypertension, September 1, 1996; 28(3): 488 - 493. [Abstract] [Full Text]